Biological significance and prognostic implications of the involvement of the sex chromosomes in the evolution of chronic myeloid leukemia (CML)
Alimena, G.; Montuoro, A.; Gastaldi, R.; Lombardi, A.; Dallapiccola, B.
Pathologica 71(1013): 392-393
1979
ISSN/ISBN: 0031-2983 PMID: 297223 Document Number: 149258
Document emailed within 1 workday
Related Documents
Lozyns'ka, M.P.; Masliak, Z.V.; Lukavets'kyĭ, L.M.; Tsiapka, O.M.; Lozyns'kyĭ, R.I. 2005: Prognostic significance of additional chromosomal abnormalities in Ph positive bone marrow cells in chronic myeloid leukemia Tsitologiia i Genetika 39(1): 26-33Suciu, S.; Neamtu, S.; Petrov, L.; Marinca, E.; Giurgiuman, M. 1983: Minute chromosomes in a case of chronic Ph1-positive myeloid leukemia Folia Haematologica 110(6): 942-947
Gao, J.S.; Zhang, G.R.; Zhu, B.X.; Xu, M.Y.; Xue, Y.Q.; Shao, J.Z.; He, Z.X.; Hu, Z.D. 1987: Clinical classification of 109 chronic myeloid leukemia cases and its correlation with Ph chromosomes Chinese Medical Journal 100(4): 333-334
Patel, R.K.; Trivedi, A.H.; Roy, S.K.; Bhachech, S.H.; Bakshi, S.R.; Bhatavdekar, J.M.; Desai, C.J.; Patel, K.M.; Shah, P.M. 1998: A complex translocation involving chromosomes 2, 9 and 22 in a patient with chronic myeloid leukemia Journal of Experimental and Clinical Cancer Research: Cr 17(4): 443-444
Reiffers, J.; Montastruc, M.; Bilhou-Nabera, C. 1990: Chronic myeloid leukemia. Diagnosis, evolution and prognosis, treatment La Revue du Praticien 40(20): 1879-1885
Boma, P.O.; Durosinmi, M.A.; Adediran, I.A.; Akinola, N.O.; Salawu, L. 2006: Clinical and prognostic features of Nigerians with chronic myeloid leukemia Nigerian Postgraduate Medical Journal 13(1): 47-52
Jonte, F.; Fernández-Fuertes, F.; Cecchini, C.; Luño, E.; Ordóñez, A.; Fernández, C.; Suárez, P.; Lausín, A.; Fernández, J. 1992: Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia Sangre 37(5): 351-354
Nowacki, P.; Zdziarska, B. 1994: Patient's age as a risk factor for central nervous system involvement in chronic myeloid leukemia Neurologia i Neurochirurgia Polska 28(1): 7-12
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Tsvetaeva, N.V.; Vinogradova, O.I.; Levina, A.A.; Tsibul'skaia, M.M.; Diagileva, O.A.; Sokolova, M.A.; Kuznetsov, S.V.; Turkina, A.G.; Khoroshko, N.D. 2002: Clinical significance of erythrocyte ferritin in refractory anemia and chronic myeloid leukemia Terapevticheskii Arkhiv 74(7): 18-22
Larrain, C.; Cruz, A.; Codoceo, V. 1984: Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases Revista Medica de Chile 112(9): 898-911
Jootar, S.; Ungkanont, A.; Chuncharunee, S.; Atichartakarn, V. 1996: Multivariate analysis of prognostic factors in Philadelphia chromosome positive chronic myeloid leukemia: an update of the first series in Thailand Asian Pacific Journal of Allergy and Immunology 14(1): 25-30
Ashariati, A.; Ugroseno, S. 2013: Profile of BCR-ABL transcript levels based on Sokal prognostic score in chronic myeloid leukemia patients treated with imatinib Acta Medica Indonesiana 45(2): 107-113
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Usman, M.; Syed, N.N.; Kakepoto, G.N.; Adil, S.N.; Khurshid, M. 2007: Chronic phase chronic myeloid leukemia: response of imatinib mesylate and significance of Sokal score, age and disease duration in predicting the hematological and cytogenetic response Journal of the Association of Physicians of India 55: 103-107
Petti, M.C.; Aloe Spiriti, M.A.; Latagliata, R.; Spadea, A.; Tirindelli, M.C.; Vegna, M.L. 1989: Acute myeloid leukemia: prognostic factors Haematologica 74(5 Suppl): 380-391
Ben Salah, N.; Gouider, E.; Aounallah Skhiri, H.; El Borgi, W.; Jouabli, M.; Ben Lakhal, F.; Jeddi, R.; Hafsia, R. 2012: Immunophenotyping in adult acute myeloid leukemia: which prognostic value? La Tunisie Medicale 90(8-9): 602-605
Buakhao, J.; Tansawet, A. 2011: Cauda equina involvement in acute myeloid leukemia relapse Journal of the Medical Association of Thailand 94(10): 1271-1275
Groffen, J.; Voncken, J.W.; van Schaick, H.; Heisterkamp, N. 1992: Animal models for chronic myeloid leukemia and acute lymphoblastic leukemia Leukemia 6(Suppl 1): 44-46